Revascularization ≈ Revascularization
View article: 2018 ESC/EACTS Guidelines on myocardial revascularization
2018 ESC/EACTS Guidelines on myocardial revascularization Open
International audience
View article
2018 ESC/EACTS Guidelines on myocardial revascularization Open
International audience
View article
PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock Open
Among patients who had multivessel coronary artery disease and acute myocardial infarction with cardiogenic shock, the 30-day risk of a composite of death or severe renal failure leading to renal-replacement therapy was lower among those w…
View article
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease Open
In patients with left main coronary artery disease and low or intermediate SYNTAX scores by site assessment, PCI with everolimus-eluting stents was noninferior to CABG with respect to the rate of the composite end point of death, stroke, o…
View article
2018 ESC/EACTS Guidelines on myocardial revascularization Open
Associations: Acute Cardiovascular Care Association (ACCA), European Association of Preventive Cardiology (EAPC), European Association of Cardiovascular Imaging (EACVI), European Association of Percutaneous Cardiovascular Interventions (EA…
View article
Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI Open
Coronary revascularization guided by iFR was noninferior to revascularization guided by FFR with respect to the risk of major adverse cardiac events at 1 year. The rate of adverse procedural signs and symptoms was lower and the procedural …
View article
Rivaroxaban in Peripheral Artery Disease after Revascularization Open
In patients with peripheral artery disease who had undergone lower-extremity revascularization, rivaroxaban at a dose of 2.5 mg twice daily plus aspirin was associated with a significantly lower incidence of the composite outcome of acute …
View article
Complete Revascularization with Multivessel PCI for Myocardial Infarction Open
Among patients with STEMI and multivessel coronary artery disease, complete revascularization was superior to culprit-lesion-only PCI in reducing the risk of cardiovascular death or myocardial infarction, as well as the risk of cardiovascu…
View article
Management of Acute Ischemic Stroke Open
Objectives: Concise “synthetic” review of the state of the art of management of acute ischemic stroke. Data Sources: Available literature on PubMed. Study Selection: We selected landmark studies, recent clinical trials, observational studi…
View article
Effect of Endovascular Contact Aspiration vs Stent Retriever on Revascularization in Patients With Acute Ischemic Stroke and Large Vessel Occlusion Open
clinicaltrials.gov Identifier: NCT02523261.
View article
Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia Open
Among patients with CLTI who had an adequate great saphenous vein for surgical revascularization (cohort 1), the incidence of a major adverse limb event or death was significantly lower in the surgical group than in the endovascular group.…
View article
Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis Open
Over 10 years of follow-up, we did not find a significant difference between patients who underwent stenting and those who underwent endarterectomy with respect to the risk of periprocedural stroke, myocardial infarction, or death and subs…
View article
Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association Open
Lower extremity peripheral artery disease (PAD) affects >230 million adults worldwide and is associated with increased risk of various adverse clinical outcomes (other cardiovascular diseases such as coronary heart disease and stroke and l…
View article
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions Open
NCT01760083.
View article
Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery Open
Background— This randomized controlled trial evaluated clinical durability of Zilver PTX, a paclitaxel-coated drug-eluting stent (DES), for femoropopliteal artery lesions. Outcomes compare primary DES versus percutaneous transluminal angio…
View article
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction Open
Among patients with severe ischemic left ventricular systolic dysfunction who received optimal medical therapy, revascularization by PCI did not result in a lower incidence of death from any cause or hospitalization for heart failure. (Fun…
View article
Free Radical Damage in Ischemia‐Reperfusion Injury: An Obstacle in Acute Ischemic Stroke after Revascularization Therapy Open
Acute ischemic stroke is a common cause of morbidity and mortality worldwide. Thrombolysis with recombinant tissue plasminogen activator and endovascular thrombectomy are the main revascularization therapies for acute ischemic stroke. Howe…
View article
Management of Coronary Disease in Patients with Advanced Kidney Disease Open
Among patients with stable coronary disease, advanced chronic kidney disease, and moderate or severe ischemia, we did not find evidence that an initial invasive strategy, as compared with an initial conservative strategy, reduced the risk …
View article
Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease Open
Among patients with stable angina and risk factors for coronary artery disease, myocardial-perfusion cardiovascular MRI was associated with a lower incidence of coronary revascularization than FFR and was noninferior to FFR with respect to…
View article
Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease Open
In the overall trial population with moderate or severe ischemia, which included 35% of participants without angina at baseline, patients randomly assigned to the invasive strategy had greater improvement in angina-related health status th…
View article
Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial Open
Aims The Hygia Chronotherapy Trial, conducted within the clinical primary care setting, was designed to test whether bedtime in comparison to usual upon awakening hypertension therapy exerts better cardiovascular disease (CVD) risk reducti…
View article
Presentation, Clinical Profile, and Prognosis of Young Patients With Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): Results From the VIRGO Study Open
Background We compared the clinical characteristics and outcomes of young patients with myocardial infarction with nonobstructive coronary arteries ( MINOCA ) versus obstructive disease (myocardial infarction due to coronary artery disease…
View article
eTICI reperfusion: defining success in endovascular stroke therapy Open
Background Revascularization after endovascular therapy for acute ischemic stroke is measured by the Thrombolysis In Cerebral Infarction (TICI) scale, yet variability exists in scale definitions. We examined the degree of reperfusion with …
View article
Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting Open
In our trial, the rate of the composite outcome of death, stroke, myocardial infarction, renal failure, or repeat revascularization at 5 years of follow-up was similar among patients who underwent off-pump CABG and those who underwent on-p…
View article
Interhospital Transfer Before Thrombectomy Is Associated With Delayed Treatment and Worse Outcome in the STRATIS Registry (Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke) Open
Background: Endovascular treatment with mechanical thrombectomy (MT) is beneficial for patients with acute stroke suffering a large-vessel occlusion, although treatment efficacy is highly time-dependent. We hypothesized that interhospital …
View article
Safety and Effectiveness of Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses Open
Background: The feasibility of intravascular lithotripsy (IVL) for modification of severe coronary artery calcification (CAC) was demonstrated in the Disrupt CAD I study (Disrupt Coronary Artery Disease). We next sought to confirm the safe…
View article
Cardiogenic Shock After Acute Myocardial Infarction Open
Cardiogenic shock occurs in up to 10% of patients immediately following acute myocardial infarction and is associated with mortality rates of nearly 40% at 30 days and 50% at 1 year. Current evidence and clinical practice guidelines suppor…
View article
Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study) Open
For patients with ACS caused by plaque erosion, conservative treatment with anti-thrombotic therapy without stenting may be an option.
View article
Diabetic foot disease: From the evaluation of the “foot at risk” to the novel diabetic ulcer treatment modalities Open
The burden of diabetic foot disease (DFD) is expected to increase in the future. The incidence of DFD is still rising due to the high prevalence of DFD predisposing factors. DFD is multifactorial in nature; however most of the diabetic foo…
View article
Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry–GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With the Guidelines) Open
Background— Sex differences in early mortality after myocardial infarction (MI) vary by age. MI with nonobstructive coronary arteries (MINOCA [<50% stenosis]) is more common among younger patients and women, and MINOCA has a better prognos…